Search filters

List of works by Sherene Loi

12INMODULATION OF IMMUNE RESPONSE IN BREAST CANCER AND CLINICAL IMPLICATIONS

70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer

scientific article

A Multifunctional Role for Adjuvant Anti-4-1BB Therapy in Augmenting Antitumor Response by Chimeric Antigen Receptor T Cells

scientific article published on 12 January 2017

A common language in neoadjuvant breast cancer clinical trials: proposals for standard definitions and endpoints

scientific article published on June 2012

A community-based model of rapid autopsy in end-stage cancer patients

scientific article published on 12 September 2016

A network meta-analysis of everolimus plus exemestane versus chemotherapy in the first- and second-line treatment of estrogen receptor-positive metastatic breast cancer

scientific article published on 5 June 2015

A randomized cross-over trial to determine the effect of Cremophor EL on the pharmacodynamics and pharmacokinetics of carboplatin chemotherapy

scientific article published on 3 July 2004

A randomized placebo-controlled study on high-dose oral algal docosahexaenoic acid supplementation in children with cystic fibrosis.

scientific article published on 21 December 2012

A three-gene model to robustly identify breast cancer molecular subtypes

scientific article published on 18 January 2012

ASCO/CAP 2018 breast cancer HER2 testing guidelines: summary of pertinent recommendations for practice in Australia

scientific article published on 07 May 2019

Abstract CT135: Uncovering the genomic heterogeneity of multifocal breast cancer

Abstract ES6-3: Tumor infiltrating lymphocytes in breast cancer

Abstract P6-01-01: RANK/RANKL expression by immunohistochemistry (IHC) in young breast cancer (BC) patients and during pregnancy: Association with clinicopathologic features, gene expression profiles and patient outcome

article

Activation of Canonical BMP4-SMAD7 Signaling Suppresses Breast Cancer Metastasis

scientific article published on 15 January 2020

Adenosine 2B Receptor Expression on Cancer Cells Promotes Metastasis

scientific article published on 24 May 2016

Adenosine Receptor 2A Blockade Increases the Efficacy of Anti-PD-1 through Enhanced Antitumor T-cell Responses

scientific article

Advancing Immunotherapy in Metastatic Breast Cancer

scientific article

Agonist immunotherapy restores T cell function following MEK inhibition improving efficacy in breast cancer

scientific article published on 19 September 2017

An immune stratification reveals a subset of PD-1/LAG-3 double-positive triple-negative breast cancers

scientific article published on 03 December 2016

Anti-ErbB-2 mAb therapy requires type I and II interferons and synergizes with anti-PD-1 or anti-CD137 mAb therapy

scientific article (publication date: 26 April 2011)

Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials

scientific article published on 12 May 2020

Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Ca

scientific article published on 2 August 2017

Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in I

scientific article published in September 2017

Association of Somatic Driver Alterations With Prognosis in Postmenopausal, Hormone Receptor-Positive, HER2-Negative Early Breast Cancer: A Secondary Analysis of the BIG 1-98 Randomized Clinical Trial

article published in 2018

Association of T-Cell Receptor Repertoire Use With Response to Combined Trastuzumab-Lapatinib Treatment of HER2-Positive Breast Cancer: Secondary Analysis of the NeoALTTO Randomized Clinical Trial

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer

Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial

scientific article published on 27 November 2019

Beyond trastuzumab: new treatment options for HER2-positive breast cancer

scientific article published on October 2011

Biology of breast cancer during pregnancy using genomic profiling

scientific article published on 13 May 2014

Breast cancer gene expression profiling: clinical trial and practice implications

scientific article

Breast ductal carcinoma in situ carry mutational driver events representative of invasive breast cancer

scientific article published on 24 March 2017

CD4⁺ follicular helper T cell infiltration predicts breast cancer survival

scientific article published on 17 June 2013

CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancer

scientific article published on 17 June 2013

CD73 promotes resistance to HER2/ErbB2 antibody therapy

scientific article published on 30 August 2017

CD73: A potential biomarker for anti-PD-1 therapy

scientific article

Castleman's disease and HIV infection in Australia.

scientific article published on May 2004

Challenges in breast cancer clinical trial design in the postgenomic era.

scientific article

Changes in peripheral and local tumor immunity after neoadjuvant chemotherapy reshape clinical outcomes in patients with breast cancer

scientific article published on 21 August 2020

Characterization and clinical evaluation of CD10+ stroma cells in the breast cancer microenvironment

scientific article published on 10 January 2012

Checkpoint blockade in the treatment of breast cancer: current status and future directions

Circulating tumour DNA in metastatic breast cancer to guide clinical trial enrolment and precision oncology: A cohort study

scientific article published on 01 October 2020

Clinical Validity and Utility of Tumor-Infiltrating Lymphocytes in Routine Clinical Practice for Breast Cancer Patients: Current and Future Directions

scientific article published on 03 August 2017

Clinical application of the 70-gene profile: the MINDACT trial

scientific article

Clinical implications of prospective genomic profiling of metastatic breast cancer patients

scientific article published on 18 August 2020

Clinical relevance of host immunity in breast cancer: from TILs to the clinic

scientific article published on 15 December 2015

Clinical significance of CD73 in triple-negative breast cancer: multiplex analysis of a phase III clinical trial.

scientific article published on 14 November 2017

Combined CDK4/6 and PI3Kα Inhibition Is Synergistic and Immunogenic in Triple-Negative Breast Cancer

scientific article

Combined immune checkpoint blockade as a therapeutic strategy for BRCA1-mutated breast cancer

scientific article

Consensus guidelines for the definition, detection and interpretation of immunogenic cell death

scientific article published on 01 March 2020

Consensus guidelines for the detection of immunogenic cell death

scientific article published on October 2014

Constitutive phosphorylated STAT3-associated gene signature is predictive for trastuzumab resistance in primary HER2-positive breast cancer

scientific article published on 3 August 2015

Correction: The Subclonal Architecture of Metastatic Breast Cancer: Results from a Prospective Community-Based Rapid Autopsy Program "CASCADE".

scientific article published on 21 April 2017

Correlation between severe infection and breast cancer metastases in the EORTC 10994/BIG 1-00 trial: Investigating innate immunity as a tumour suppressor in breast cancer

scientific article published on 24 December 2016

Cyclin E1 Expression and Palbociclib Efficacy in Previously Treated Hormone Receptor–Positive Metastatic Breast Cancer

scientific article published on 26 February 2019

Deciphering clonality in aneuploid breast tumors using SNP array and sequencing data

scientific article

Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade

scientific article

Dissecting the heterogeneity of triple-negative breast cancer

scientific article published on 26 March 2012

Dual PD-1 and CTLA-4 Checkpoint Blockade Promotes Antitumor Immune Responses through CD4Foxp3 Cell-Mediated Modulation of CD103 Dendritic Cells

article

Effects of Estrogen Receptor and Human Epidermal Growth Factor Receptor-2 Levels on the Efficacy of Trastuzumab: A Secondary Analysis of the HERA Trial

scientific article published on 21 April 2016

Efficacy and Determinants of Response to HER Kinase Inhibition in HER2-Mutant Metastatic Breast Cancer

scientific article published on 05 December 2019

Efficacy of late line pertuzumab with trastuzumab and chemotherapy in HER2-positive metastatic breast cancer: An Australian case series

scientific article published on 19 July 2019

Elucidating prognosis and biology of breast cancer arising in young women using gene expression profiling.

scientific article

Exercise as a diagnostic and therapeutic tool for the prevention of cardiovascular dysfunction in breast cancer patients

article published in 2018

FGFR2 amplification in metastatic hormone-positive breast cancer and response to an mTOR inhibitor.

scientific article published in August 2017

Feasibility of developing reliable gene expression modules from FFPE derived RNA profiled on Affymetrix arrays

scientific article published in PLoS ONE

Fine-tuning chemotherapy in the era of dual HER2 targeting

Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind

scientific article

Fulvestrant--ready to start its journey in the breast cancer adjuvant endocrine world?

scientific article published in February 2005

Gene Profiling Assay and Application: The Predictive Role in Primary Therapy

article

Gene expression profiling identifies activated growth factor signaling in poor prognosis (Luminal-B) estrogen receptor positive breast cancer

scientific article

Gene expression profiling in breast cancer challenges the existence of intermediate histological grade.

scientific article

Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis

scientific article (publication date: 15 February 2006)

Gene modules and response to neoadjuvant chemotherapy in breast cancer subtypes: a pooled analysis.

scientific article

Gene signature evaluation as a prognostic tool: challenges in the design of the MINDACT trial

scientific article published on October 2006

Geospatial immune variability illuminates differential evolution of lung adenocarcinoma

scientific article published on 27 May 2020

HER kinase inhibition in patients with HER2- and HER3-mutant cancers

scientific article published on 31 January 2018

HER2-overexpressing breast cancer: time for the cure with less chemotherapy?

scientific article

Hormone receptor positive, HER2 negative metastatic breast cancer: A systematic review of the current treatment landscape

scientific article published on March 2016

Host Antitumor Immunity Plays a Role in the Survival of Patients With Newly Diagnosed Triple-Negative Breast Cancer

scientific article published on 01 September 2014

INPP4B promotes PI3Kα-dependent late endosome formation and Wnt/β-catenin signaling in breast cancer

scientific article published on 25 May 2021

Identification of functional networks of estrogen- and c-Myc-responsive genes and their relationship to response to tamoxifen therapy in breast cancer

scientific article

Identification of novel Ras-cooperating oncogenes in Drosophila melanogaster: a RhoGEF/Rho-family/JNK pathway is a central driver of tumorigenesis

scientific article

Immune Infiltration in Invasive Lobular Breast Cancer

scientific article published on 20 February 2018

Immune response in breast cancer brain metastases and their microenvironment: the role of the PD-1/PD-L axis

scientific article published on 27 April 2016

Immune targeting in breast cancer: in whom and with what?

scientific article published in May 2015

Immunity and HER2-positive disease: never stop questioning.

scientific article

Immunomodulation via Chemotherapy and Targeted Therapy: A New Paradigm in Breast Cancer Therapy?

scientific article

Improved Treatment of Breast Cancer with Anti-HER2 Therapy Requires Interleukin-21 Signaling in CD8+ T Cells

scientific article published on 7 January 2016

In the beginning, there was chaos: A perspective on the development of immuno-oncological biomarkers

article

Inhibition of RANK signaling in breast cancer induces an anti-tumor immune response orchestrated by CD8+ T cells

scientific article published on 10 December 2020

Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis

scientific article published on 07 July 2017

Integrative proteomic and gene expression analysis identify potential biomarkers for adjuvant trastuzumab resistance: analysis from the Fin-her phase III randomized trial

scientific article published on 3 September 2015

Intracranial Efficacy and Survival With Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2-Positive Breast Cancer With Brain Metastases in the HER2CLIMB Trial

scientific article published on 29 May 2020

Investigating the positive relationship between tumor-infiltrating lymphocytes and trastuzumab therapy

scientific article published in January 2014

Long-term Pooled Safety Analysis of Palbociclib in Combination With Endocrine Therapy for HR+/HER2- Advanced Breast Cancer.

scientific article

Looking Deep Into the Heterogeneity of Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Can We Understand It Better?

scientific article published on 11 January 2016

Low residual proliferation after short-term letrozole therapy is an early predictive marker of response in high proliferative ER-positive breast cancer.

scientific article published on 14 November 2011

Lucitanib for the Treatment of HR+/HER2- Metastatic Breast Cancer: Results from the Multicohort Phase II FINESSE Study

scientific article published on 16 October 2019

Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade

scientific article published on 21 October 2019

Magnitude of trastuzumab benefit in patients with HER2-positive, invasive lobular breast carcinoma: results from the HERA trial

scientific article published on 15 April 2013

Mechanisms of resistance of chemotherapy in early-stage triple negative breast cancer (TNBC).

scientific article published on 28 June 2017

Medical comorbidity in psychogeriatric patients.

scientific article published on July 2011

Metastatic Breast Cancer: TIL it is Too Late

scientific article published on 02 December 2019

Molecular Forecasting of Breast Cancer: Time to Move Forward With Clinical Testing

scientific article published on 01 February 2006

Molecular analysis of hormone receptor positive (luminal) breast cancers: what have we learnt?

scientific article

Molecular heterogeneity of luminal breast cancer

scientific article published on 16 November 2011

Molecular pathways: involvement of immune pathways in the therapeutic response and outcome in breast cancer.

scientific article published on 20 December 2012

Molecular segmentation of luminal breast: Reality in 2015?

scientific article published on 5 August 2015

Molecular subclasses of breast cancer: how do we define them? The IMPAKT 2012 Working Group Statement.

scientific article published on December 2012

Mouse Models of Tumor Immunotherapy

scientific article published on 19 January 2016

Neoadjuvant Interferons: Critical for effective PD-1 based immunotherapy in TNBC.

scientific article published on 28 August 2017

Neoadjuvant buparlisib plus trastuzumab and paclitaxel for women with HER2+ primary breast cancer: A randomised, double-blind, placebo-controlled phase II trial (NeoPHOEBE).

scientific article published on 15 September 2017

Neratinib is effective in breast tumors bearing both amplification and mutation of ERBB2 (HER2)

scientific article published on 09 October 2018

Novel Targeted Agents and Immunotherapy in Breast Cancer

scientific article

Obesity and outcomes in premenopausal and postmenopausal breast cancer

scientific article published in July 2005

Oncogene addiction and immunity: clinical implications of tumour infiltrating lymphocytes in breast cancers overexpressing the HER2/neu oncogene

scientific article

Optimising patient recall of adverse events over prolonged time periods.

scientific article

Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer

Oxaliplatin combined with infusional 5-fluorouracil and concomitant radiotherapy in inoperable and metastatic rectal cancer: a phase I trial

scientific article published on February 2005

PIK3CA genotype and a PIK3CA mutation-related gene signature and response to everolimus and letrozole in estrogen receptor positive breast cancer

scientific article

PIK3CA mutations are associated with decreased benefit to neoadjuvant human epidermal growth factor receptor 2-targeted therapies in breast cancer

scientific article published on 05 January 2015

PIK3CA mutations are associated with lower rates of pathologic complete response to anti-human epidermal growth factor receptor 2 (her2) therapy in primary HER2-overexpressing breast cancer

scientific article published on 8 September 2014

PIK3CA mutations are associated with reduced pathological complete response rates in primary HER2-positive breast cancer: pooled analysis of 967 patients from five prospective trials investigating lapatinib and trastuzumab.

scientific article

PIK3CA mutations associated with gene signature of low mTORC1 signaling and better outcomes in estrogen receptor-positive breast cancer

scientific article

PIK3CA mutations in breast cancer: reconciling findings from preclinical and clinical data

scientific article (publication date: 23 January 2014)

Palbociclib Combined with Fulvestrant in Premenopausal Women with Advanced Breast Cancer and Prior Progression on Endocrine Therapy: PALOMA-3 Results

scientific article

Palbociclib in Combination With Fulvestrant in Women With Hormone Receptor-Positive/HER2-Negative Advanced Metastatic Breast Cancer: Detailed Safety Analysis From a Multicenter, Randomized, Placebo-Controlled, Phase III Study (PALOMA-3).

scientific article published on July 2016

Palbociclib in Hormone-Receptor-Positive Advanced Breast Cancer

scientific article

Passion for Immune checkpoint blockade in triple negative breast cancer? Comment on the IMpassion130 study

article

Pathway level alterations rather than mutations in single genes predict response to HER2-targeted therapies in the neo-ALTTO trial

scientific article published in January 2017

Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study

scientific article published on 01 March 2019

Pembrolizumab monotherapy for previously untreated, PD-L1-positive, metastatic triple-negative breast cancer: cohort B of the phase II KEYNOTE-086 study

scientific article published on 01 March 2019

Pertuzumab: new hope for patients with HER2-positive breast cancer

scientific article published on 21 August 2012

Pervasive chromosomal instability and karyotype order in tumour evolution

scientific article published on 02 September 2020

Phase 2 study of pembrolizumab (pembro) monotherapy for previously treated metastatic triple-negative breast cancer (mTNBC): KEYNOTE-086 cohort A

Phase 2 study of pembrolizumab as first-line therapy for PD-L1–positive metastatic triple-negative breast cancer (mTNBC): Preliminary data from KEYNOTE-086 cohort B

Phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin pathway inhibition: a breakthrough in the management of luminal (ER+/HER2-) breast cancers?

scientific article

Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer

scientific article published on 12 May 2020

Pivotal role of innate and adaptive immunity in anthracycline chemotherapy of established tumors

scientific article published on 6 June 2011

Plasma ESR1 Mutations and the Treatment of Estrogen Receptor-Positive Advanced Breast Cancer.

scientific article published on 06 June 2016

Precision medicine for metastatic breast cancer--limitations and solutions.

scientific article published on 21 July 2015

Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen

scientific article

Prediction of breast cancer prognosis using gene set statistics provides signature stability and biological context

scientific article

Predictors of prolonged benefit from palbociclib plus fulvestrant in women with endocrine-resistant hormone receptor–positive/human epidermal growth factor receptor 2–negative metastatic breast cancer in PALOMA-3

scientific article published in Novemer 2018

Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-98

scientific article

Prognostic, predictive abilities and concordance of BCL2 and TP53 protein expression in primary breast cancers and axillary lymph-nodes: a retrospective analysis of the Belgian three arm study evaluating anthracycline vs CMF adjuvant chemotherapy

scientific article published on 24 April 2014

Proposals for uniform collection of biospecimens from neoadjuvant breast cancer clinical trials: timing and specimen types

scientific article published in November 2011

Publisher Correction: Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis

scientific article published on 01 December 2018

Quality of life with palbociclib plus fulvestrant in previously treated hormone receptor-positive, HER2-negative metastatic breast cancer: patient-reported outcomes from the PALOMA-3 trial

scientific article published on 30 March 2016

RANK-ligand (RANKL) expression in young breast cancer patients and during pregnancy

scientific article

RAS/MAPK Activation Is Associated with Reduced Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Therapeutic Cooperation Between MEK and PD-1/PD-L1 Immune Checkpoint Inhibitors

scientific article published on 29 October 2015

RNA Sequencing to Predict Response to Neoadjuvant Anti-HER2 Therapy: A Secondary Analysis of the NeoALTTO Randomized Clinical Trial.

scientific article published on 29 September 2016

Relevance of tumor-infiltrating lymphocytes in breast cancer

scientific article (publication date: 2015)

Reply to A. Ocaña et al and P.G. Tsoutsou et al.

scientific article published on 9 March 2015

Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group

scientific article published on 12 May 2020

Research resource: nuclear receptors as transcriptome: discriminant and prognostic value in breast cancer

scientific article

Role of TP53 mutations in triple negative and HER2-positive breast cancer treated with neoadjuvant anthracycline/taxane-based chemotherapy

scientific article published on 7 September 2016

Safety and Antitumor Activity of Pembrolizumab in Patients with Estrogen Receptor‒Positive/Human Epidermal Growth Factor Receptor 2‒Negative Advanced Breast Cancer.

scientific article published on 20 March 2018

Scoring of tumor-infiltrating lymphocytes: From visual estimation to machine learning

scholarly article by F Klauschen et al published October 2018 in Seminars in Cancer Biology

Serum Human Epidermal Growth Factor 2 Extracellular Domain as a Predictive Biomarker for Lapatinib Treatment Efficacy in Patients With Advanced Breast Cancer

scientific article

Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape

scientific article published on 22 July 2012

Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis

scientific article published on 25 June 2018

Somatic mutation profiling and associations with prognosis and trastuzumab benefit in early breast cancer

scientific article published on 05 June 2013

Somatic mutation, copy number and transcriptomic profiles of primary and matched metastatic estrogen receptor-positive breast cancers.

scientific article published on October 2016

Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group

scientific article published on July 2016

Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series

scientific article published in June 2007

Tamoxifen in early-stage estrogen receptor-positive breast cancer: overview of clinical use and molecular biomarkers for patient selection

scientific article

Targeting the PI3K/AKT/mTOR and Raf/MEK/ERK pathways in the treatment of breast cancer

scientific article

Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacy

scientific article

The AURORA pilot study for molecular screening of patients with advanced breast cancer-a study of the breast international group

scientific article

The E3-ligase E6AP Represses Breast Cancer Metastasis via Regulation of ECT2-Rho Signaling

scientific article published on 26 May 2016

The Subclonal Architecture of Metastatic Breast Cancer: Results from a Prospective Community-Based Rapid Autopsy Program "CASCADE".

scientific article

The adverse mental health of carers: Does the patient diagnosis play a role?

scientific article published on 23 June 2015

The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014.

scientific article published on 11 September 2014

The genetic landscape and clonal evolution of breast cancer resistance to palbociclib plus fulvestrant in the PALOMA-3 trial

scientific article published on 11 September 2018

The genomic landscape of breast cancer and its interaction with host immunity

scientific article

The impact of ethnicity on efficacy and toxicity of cyclin D kinase 4/6 inhibitors in advanced breast cancer: a meta-analysis

article

The prevalence and clinical relevance of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ of the breast.

scientific article published on February 2017

The use of gene-expression profiling to better understand the clinical heterogeneity of estrogen receptor positive breast cancers and tamoxifen response

scientific article published on 7 November 2006

Time to move forward from “first-generation” prognostic gene signatures in early breast cancer

article

Tissue-resident memory T cells in breast cancer control and immunotherapy responses

scientific article published on 28 February 2020

Towards evidence-based use of serum tumour marker requests: an audit of use in a tertiary hospital

scientific article published on 01 September 2004

Trastuzumab-associated cardiac events in the Persephone trial

scientific article published on 22 November 2016

Triple-negative breast cancer: recent treatment advances

scientific article published on 02 August 2019

Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer

scientific article published on 11 December 2019

Tumor PIK3CA Genotype and Prognosis in Early-Stage Breast Cancer: A Pooled Analysis of Individual Patient Data

scientific article published on 22 February 2018

Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial

scientific article

Tumor-Infiltrating Lymphocytes and Associations With Pathological Complete Response and Event-Free Survival in HER2-Positive Early-Stage Breast Cancer Treated With Lapatinib and Trastuzumab: A Secondary Analysis of the NeoALTTO Trial

scientific article published on July 2015

Tumor-infiltrating lymphocytes and response to neoadjuvant chemotherapy with or without carboplatin in human epidermal growth factor receptor 2-positive and triple-negative primary breast cancers

scientific article published on 22 December 2014

Tumor-infiltrating lymphocytes, breast cancer subtypes and therapeutic efficacy

scientific article published on 30 April 2013

Tumour infiltrating lymphocytes (TILs) in breast cancer during pregnancy

scientific article published on 18 February 2015

Tumour infiltrating lymphocytes in breast cancer: increasing clinical relevance

scientific article

Tumour-infiltrating lymphocytes and the emerging role of immunotherapy in breast cancer

scientific article published on 31 December 2016

Tumour-infiltrating lymphocytes in advanced HER2-positive breast cancer treated with pertuzumab or placebo in addition to trastuzumab and docetaxel: a retrospective analysis of the CLEOPATRA study

scientific article published on 06 December 2016

Uncovering the genomic heterogeneity of multifocal breast cancer

scientific article

Utility of prognostic genomic tests in breast cancer practice: The IMPAKT 2012 Working Group Consensus Statement

scientific article

Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer

scientific article

Paulina is supported by:

About Paulina

Help